Aspirin reduces blood cholesterol in copper-deficient rats: A potential antioxidant agent?

Metabolism: Clinical and Experimental

Volumn 50, Issue 5, 2001, Pages 558-561

  Fields, Meira ^a   Lewis, Charles G ^b   Bureau, Isabelle ^b  

^a AGRICULTURAL RESEARCH SERVICE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CHOLESTEROL; COPPER; IRON; SUPEROXIDE DISMUTASE;

ANIMAL DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; COPPER DEFICIENCY; DRUG EFFECT; ENZYME ACTIVITY; HYPOCHOLESTEROLEMIA; LIPID PEROXIDATION; LIVER LEVEL; LIVER METABOLISM; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT;

EID: 0035340549     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1053/meta.2001.22513     Document Type: Article

References (34)

1. 1. Fields M, Lewis CG: Hepatic iron overload may contribute to hypertriglyceridemia and hypercholesterolemia in copper-deficient rats. Metabolism 46:377-381, 1997
2. 2. Bureau I, Lewis CG, Fields M: Effect of hepatic iron on hypercholesterolemia and hypertriglyceridemia in copper-deficient fructosefed rats. Nutrition 14:366-371, 1998
3. 3. Fields M, Lewis CG: Starch diets high in iron can duplicate the severity of copper deficency in rats fed fructose. J Med Food 1:193-199, 1999
4. 4. McCord JM, Fridovich I: Superoxide dismutase: Aan enzymatic function for erythrocuprein (hemocuprein). J Biol Chem 244:6049-6055, 1969
5. 5. Paynter DI, Moir RJ, Underwood EJ: Changes in activity of Cu-Zn Superoxide dismutase enzyme in tissues of the rats with changes in dietary copper. J Nutr 109:1570-1578, 1987
6. 6. Balevska RS, Russanov EM, Kassabova TA: Studies on lipid peroxidation in rat liver by copper deficiency. Int J Biochem 13:489-493, 1981
7. 7. Fields M, Ferretti RJ, Smith JC, et al: Effects of the interaction of type of dietary carbohydrate with copper deficiency on lipid peroxidation in rat tissues. Biol Trace Elem Res 6:379-391, 1984
8. 8. Williams DM, Kennedy FS, Green BG: Hepatic iron accumulation in copper-deficient rats. Br J Nutr 50:653-660, 1983
9. 9. Rowley D, Halliwell B: Superoxide-dependent formation of hydroxyl radicals from NADH and NADPH in the presence of iron salts. FEBS Lett 142:139-141, 1982
10. 10. Fields M, Lewis CG, Lure MD, et al: Low dietary iron prevents free radicals formation and heart pathology of copper-deficient rats fed fructose. Proc Soc Exp Biol Med 202:225-230, 1993
11. 11. Whittaker P, Warner WG, Chanderbahn RF, et al: Effects of alpha-tocopherol and beta-carotene on hepatic lipid peroxidation and blood lipids in rats with dietary iron overload. Nutr Cancer 25:119-128, 1996
12. 12. Chen X, Xue A, Morris VC, et al: Effect of selenium deficiency on the chronic toxicity of adriamycin in rats. J Nutr 116:2453-2465, 1986
13. 13. Fields M, Lewis CG, Lure MD, et al: The severity of copper deficiency can be ameliorated by deferoxamine. Metabolism 40:105-108, 1991
14. 14. Woodbury DM: Analgesic-antipyretics, anti-inflammatory agents, and inhibitors of uric acid synthesis, in Goodman LS (ed): The Pharmacological Basis of Therapeutics (ed 4). London, UK, Gilman, McMillan, 1970, pp 314-347
15. 15. Hammond EC, Garfinkel L: Aspirin and coronary heart disease: Findings of a prospective study. Br Med J 2:269-271, 1975
16. 16. Fuster V, Dyken ML, Vokonas PS, et al: Aspirin as a therapeutic agent in cardiovascular disease - Special writing group. Circulation 87:659-675, 1993
17. 17. Oberle S, Polte T, Abate A, et al: Aspirin increases ferritin synthesis in endothelial cells. A novel antioxidant pathway. Circ Res 82:1016-1020, 1998
18. 18. Allen KGD, Klevay LM: Cholesterolemia and cardiovascular abnormalities in rats caused by copper deficiency. Atherosclerosis 29:81-93, 1978
19. 19. Al-Othman AA, Rosenstein AF, Lei KY: Pool size and concentration of plasma cholesterol are increased and tissue levels are reduced during early stages of copper deficiency in rats. J Nutr 124:628-635, 1994
20. 20. Klevay LM: Aspirin hypocholesterolemia associated with increased microsomal copper in liver. Nutr Res 6:1281-1292, 1986
21. 21. Anonymous: American Institute of Nutrition: Report of the AIN Ad Hoc Committee for Standards on Nutritional Studies. J Nutr 107: 1340-1348, 1977
22. 22. Anonymous: American Institute of Nutrition: Second Report of the Ad Hoc Committee on Standards for Nutritional Studies. J Nutr 110:1726, 1980
23. 23. Hill AD, Patterson KY, Veillon C, et al: Digestion of biological materials for mineral analyses using a combination of wet and dry ashing. Anal Chem 25:2340-2342, 1986
24. 24. Allen KGD, Arthur JR, Morrice PC, et al: Copper deficiency and tissue glutathione concentrations in the rat. Proc Soc Exp Biol Med 187:38-43, 1988
25. 25. Sangabe K, Chao PY, Allen KGD: Inhibition of elevated hepatic glutathione abolishes copper deficiency cholesterolemia. FASEB J 6:2467-2473, 1992
26. 26. Hermann M, Kapiotis S, Hofbauer R, et al: Salicylate promotes myeloperoxidase-initiated LDL oxidation: Antagonization by its metabolite gentisic acid. Free Radic Biol Med 26:1253-1260, 1999
27. 27. Gutteridge JMC, Rowley DA, Haliwell B: Superoxide-dependent formation of hydroxyl radicals in the presence of iron salts. Biochem J 199:263-265, 1981
28. 28. Lipschitz DA, Cook JD, Finch CA: A clinical evaluation of serum ferritin as an index of iron stores. N Engl J Med 290:1213-1216, 1974
29. 29. Blake DR, Waterworth RF, Bacon PA: Assessment of iron stores in inflammation by assay of ferritin concentration. Br Med J 283:1147-1148, 1981
30. 30. Fields M, Bureau I, Lewis CG: Ferritin is not an indicator of available hepatic iron stores in anemia of copper deficiency in rats. Clin Chem 43:1457-1459, 1997
31. 31. Salonen JT, Nyssönen K, Korpela H, et al: High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation 86:803-811, 1992
32. 32. Jucket MB, Balla J, Balla G, et al: Ferritin protects endothelial cells from oxidized low density lipoprotein in vitro. Am J Pathol 147:782-789, 1995
33. 33. Koch H, Knapp DE: Utilization of analgesic drugs in office-based ambulatory care: National ambulatory medical care survey. NCHS Adv Data 96:1-10, 1984
34. 34. Third Report on Nutrition Monitoring in the United States, vol 1. Washington, DC, US Government Printing Office, 1995